New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality

M.D. Anderson Cancer Center

Status

Completed

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Treatments

Procedure: Magnetic Resonance Spectroscopic Imaging

Procedure: Magnetic Resonance Imaging

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT03980535

NCI-2019-02654 (Registry Identifier)

2011-0542 (Other Identifier)

Details and patient eligibility

About

This trial studies how well new magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) software works in improving the image quality of scans in both patients and healthy volunteers. Improving the image quality of MRI and MRSI through new software may lead to implementation of these techniques and better clinical care for patients.

Full description

PRIMARY OBJECTIVE:

I. To help develop and/or optimize new magnetic resonance (MR) imaging and spectroscopy applications and analysis software in order to provide the best MR services for our patients.

OUTLINE:

Patients undergo an additional investigational MRI or MRSI sequence along with the standard MRI or MRSI. Healthy volunteers undergo an investigational MRI or MRSI sequence. Healthy volunteers may also undergo an additional standard sequence if there is one that can be compared to the investigational sequence. All MRI or MRSI procedures, including the standard MRI or MRSI, are no longer than 60 minutes.

Enrollment

273 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients who are scheduled for routine MR imaging or spectroscopy examinations at MD Anderson Cancer Center (MDACC).
Written informed consent will be obtained from each subject scanned who enrolled to individual sub-project under this protocol.
HEALTHY VOLUNTEERS: Written informed consent will be obtained from each subject scanned who enrolled to individual sub-project under this protocol

Exclusion criteria

No pregnant subjects will be enrolled
No one under 18 years of age will be enrolled
No investigational devices or drugs will be used.
No contraindications to MR exam(s)
HEALTHY VOLUNTEERS: No pregnant subjects will be enrolled
HEALTHY VOLUNTEERS: No one under 18 years of age will be enrolled
HEALTHY VOLUNTEERS: No investigational devices or drugs will be used
HEALTHY VOLUNTEERS: No contraindications to MR exam(s) - healthy volunteers will use the same screening process utilized for MDACC patients (DI Patient Record - Part I, MR Screening Section)
HEALTHY VOLUNTEERS: Healthy volunteers (including healthy MD Anderson employee volunteers) under the direct report of a sub-project principal investigator (PI) will be excluded for that specific sub-project.